Evidence map›Paper›PMID 32749220›Full record

ArticleeLife2020

Heterogeneous somatostatin-expressing neuron population in mouse ventral tegmental area.

Elina Nagaeva, Ivan Zubarev, Carolina Bengtsson Gonzales, Mikko Forss, Kasra Nikouei, Elena de Miguel, Lauri Elsilä, Anni-Maija Linden, Jens Hjerling-Leffler, George J Augustine and 1 more

Abstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Alzheimer's Pathology Enhances Excitatory Synaptic Input and Integration in VTA Dopamine Neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Increased sucrose consumption in mice gene-targeted forFrontiers in molecular neuroscience · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. The Therapeutic Potential of Psilocybin.Molecules (Basel, Switzerland) · 2021
    Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Elina NagaevaDepartment of Pharmacology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.ORCID 0000-0003-2828-6234
Ivan ZubarevDepartment of Neuroscience and Biomedical Engineering, Aalto University, Espoo, Finland.ORCID 0000-0002-1620-8485
Carolina Bengtsson GonzalesDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Mikko ForssDepartment of Pharmacology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Kasra NikoueiDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Elena de MiguelDepartment of Pharmacology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Lauri ElsiläDepartment of Pharmacology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-9744-4753
Anni-Maija LindenDepartment of Pharmacology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Jens Hjerling-LefflerDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
George J AugustineLee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.ORCID 0000-0001-7408-7485
Esa R KorpiDepartment of Pharmacology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.ORCID 0000-0003-0683-4009

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cellular architecture of the ventral tegmental area (VTA), the main hub of the brain reward system, remains only partially characterized. To extend the characterization to inhibitory neurons, we have identified three distinct subtypes of somatostatin (Sst)-expressing neurons in the mouse VTA. These neurons differ in their electrophysiological and morphological properties, anatomical localization, as well as mRNA expression profiles. Importantly, similar to cortical Sst-containing interneurons, most VTA Sst neurons express GABAergic inhibitory markers, but some of them also express glutamatergic excitatory markers and a subpopulation even express dopaminergic markers. Furthermore, only some of the proposed marker genes for cortical Sst neurons were expressed in the VTA Sst neurons. Physiologically, one of the VTA Sst neuron subtypes locally inhibited neighboring dopamine neurons. Overall, our results demonstrate the remarkable complexity and heterogeneity of VTA Sst neurons and suggest that these cells are multifunctional players in the midbrain reward circuitry.

Indexed as

AnimalsElectrophysiological PhenomenaFemaleGene Expression ProfilingInterneuronsMaleMiceMice, Inbred C57BLNeuronsNeurotransmitter AgentsSomatostatinVentral Tegmental AreaNeurotransmitter AgentsSomatostatindopamineGABAglutamatemidbrainmouseneuron subtypesneurosciencereward

Identifiers

PMID32749220
PMCPMC7440918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.